Systematic Review to Identify Predictors of Treatment Response to Neuromodulation in Patients With Neuropathic Pain-Protocol

被引:0
|
作者
Kansal, Anu [1 ,5 ]
Duarte, Rui [2 ]
Copley, Sue [1 ]
Warren, Fiona C. [3 ]
Taylor, Rod S. [4 ]
Eldabe, Sam [1 ]
机构
[1] James Cook Univ Hosp, Dept Pain Med, Middlesbrough, England
[2] Univ Liverpool, Liverpool Reviews & Implementat Grp, Liverpool, England
[3] Univ Exeter, Coll Med & Hlth, Exeter, England
[4] Univ Glasgow, Inst Hlth & Well Being, Glasgow, Scotland
[5] James Cook Univ Hosp, Dept Pain & Anaesthesia, Murray Bldg, Marton Rd, Middlesbrough TS4 3BW, England
来源
NEUROMODULATION | 2023年 / 26卷 / 08期
关键词
Chronic pain; neuropathic pain; patient characteristics; predictor; spinal cord stimulation; SPINAL-CORD STIMULATION; BACK SURGERY SYNDROME; DIABETIC PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED-TRIALS; DICHOTOMOUS OUTCOME MEASURES; COST-EFFECTIVENESS; GENERAL-POPULATION; MULTICENTER; METAANALYSES; PREVALENCE;
D O I
10.1016/j.neurom.2022.07.010
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: Patients who suffer from long-term, neuropathic pain that proves refractory to conventional medical management are high consumers of health care resources and experience poorer physical and mental health than people with other forms of pain. Pharmacologic treatments have adverse effects; nonpharmacologic interventions have limitations. Spinal cord stimulation (SCS) is an effective treatment for neuropathic pain, although 30% to 40% of patients fail to achieve acceptable levels of pain relief. There are currently no objective methods to predict the success of SCS to treat neuropathic pain, and therefore, it is important to understand which patient factors may be predictive of a lack of response to SCS, to inform future patient treatment options. This study proposes a protocol for a systematic review and meta-analysis of published studies to examine these pre-dictive factors. Materials and Methods: Several bibliographic databases will be searched to identify relevant studies published since 2012 that provide data on patient characteristics (eg, age, gender, pain severity) as predictors of SCS outcomes of pain, function, and health-related quality of life. Two independent reviewers will screen citations; data will be extracted after full-text screening. Risk of bias will be assessed using the Quality In Prognosis Studies tool. Results: A formal quantitative synthesis is planned in which data from studies with the same predictive factors are available; this will be considered for pooling into separate meta-analyses. In cases of high heterogeneity or inconsistency in the data, subgroup analysis will be conducted. Conclusions: This study seeks to provide a contemporary review of patient predictors of success of neuromodulation for neuropathic pain. We anticipate that findings may guide the use of neuromodulation in patient subgroups and the design and reporting of future clinical studies in this field.
引用
收藏
页码:1493 / 1498
页数:6
相关论文
共 50 条
  • [31] Psilocybin and chronic neuropathic pain: a systematic review
    Jevotovsky, David S.
    Chopra, Harman
    Pak, Daniel J.
    Durbhakula, Shravani
    Shustorovich, Alexander
    Juneja, Tanya
    Broachwala, Mustafa Y.
    Alfarra, Tariq
    Silver, Caroline
    Kreitzer, Greg
    Oreoluwa, Philip
    Weissman, Braden B.
    Alfarra, Abraham
    Mayrsohn, Brian G.
    Orhurhu, Vwaire
    Emerick, Trent
    Furnish, Timothy
    Castellanos, Joel P.
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2024,
  • [32] Treatments of traumatic neuropathic pain: a systematic review
    Yao, Chenglun
    Zhou, Xijie
    Zhao, Bin
    Sun, Chao
    Poonit, Keshav
    Yan, Hede
    [J]. ONCOTARGET, 2017, 8 (34) : 57670 - 57679
  • [33] NEUROMODULATION IN CHRONIC PELVIC PAIN: A SYSTEMATIC REVIEW.
    Vrijens, D.
    Marcelissen, T.
    Jairam, R.
    De Ruiter, B.
    van Koeveringe, G.
    Van Kerrebroeck, P.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S460 - S461
  • [34] Capsaicinoids in the treatment of neuropathic pain: a review
    Peppin, John F.
    Pappagallo, Marco
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (01) : 22 - 32
  • [35] Pregabalin for the treatment of neuropathic pain in adults: a systematic review of randomized controlled trials
    Wang, Dong
    Bao, Jing-Bo
    Zhang, Kai
    Ju, Long-Fang
    Yu, Ling-Zhi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 16 - 29
  • [36] A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice
    Aiyer, Rohit
    Mehta, Neel
    Gungor, Semih
    Gulati, Amitabh
    [J]. CLINICAL JOURNAL OF PAIN, 2018, 34 (05): : 450 - 467
  • [37] Diagnostic utility of patient history, clinical examination and screening tool data to identify neuropathic pain in low back-related leg pain: protocol for a systematic review
    Mistry, Jai
    Heneghan, Nicola R.
    Noblet, Timothy
    Falla, Deborah
    Rushton, Alison
    [J]. BMJ OPEN, 2019, 9 (11):
  • [38] The prevalence of neuropathic pain is high after treatment for breast cancer: a systematic review
    Ilhan, Emre
    Chee, Edwin
    Hush, Julia
    Moloney, Niamh
    [J]. PAIN, 2017, 158 (11) : 2082 - 2091
  • [39] Predictors of multidisciplinary rehabilitation outcomes in patients with chronic musculoskeletal pain: protocol for a systematic review and meta-analysis
    Elena Tseli
    Wilhelmus Johannes Andreas Grooten
    Britt-Marie Stålnacke
    Katja Boersma
    Paul Enthoven
    Björn Gerdle
    Björn Olov Äng
    [J]. Systematic Reviews, 6
  • [40] Predictors of multidisciplinary rehabilitation outcomes in patients with chronic musculoskeletal pain: protocol for a systematic review and meta-analysis
    Tseli, Elena
    Grooten, Wilhelmus Johannes Andreas
    Stalnacke, Britt-Marie
    Boersma, Katja
    Enthoven, Paul
    Gerdle, Bjorn
    Ang, Bjorn Olov
    [J]. SYSTEMATIC REVIEWS, 2017, 6